Tucson, AZ, United States of America

Klearchos K Papas

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 5 EPO patents. Top assignees: The University of Arizona, Giner, Inc., Giner Life Sciences, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klearchos K Papas. Retrieved from https://idiyas.com/inventor/klearchos-k-papas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 18(Granted Patents)


Location History:

  • Maple Grove, MN (US) (2018)
  • Tucson, AZ (US) (2019 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Klearchos K. Papas

Introduction

Klearchos K. Papas is an innovative inventor based in Tucson, Arizona, renowned for his contributions to the fields of biomedical engineering and therapeutic applications. With a portfolio of 12 patents, Klearchos has dedicated his career to advancing technologies that improve health outcomes, particularly in the regulation of blood glucose through encapsulation devices.

Latest Patents

Among his latest inventions is the "Encapsulation Device Systems with Oxygen Sensors with or without Exogenous Oxygen Delivery." This advanced system is designed for therapeutic applications that include regulating blood glucose levels. The encapsulation device features integrated oxygen sensors that allow real-time measurements of oxygen levels related to housed cells, such as islet cells and stem-cell-derived beta cells. The system also includes an exogenous oxygen delivery mechanism, ensuring the provision of adequate oxygen to the cells within the device.

Another groundbreaking patent is focused on "Methods and Systems for Real-Time Assessment of Cells in Encapsulation Devices Pre-and Post-Transplantation." This innovation utilizes temperature regulation to lower metabolic levels of the cells, thereby reducing their oxygen requirements. It features oxygen sensors at both the inlet and outlet of the implantable device, facilitating the calculation of oxygen consumption rates, which are critical indicators of cell viability. This method is versatile and applicable to various cell types, including hepatocytes, heart cells, and muscle cells.

Career Highlights

Klearchos K. Papas has built an impressive career through his work at notable organizations, including the University of Arizona and Giner, Inc. His research and inventions have significantly contributed to advancements in medical devices and therapies, showcasing his commitment to innovation in healthcare.

Collaborations

Throughout his career, Klearchos has collaborated with other professionals in the field, including Linda A. Tempelman and Simon G. Stone. These collaborations have fostered an environment of creativity and have propelled the development of cutting-edge technologies in the biomedical sector.

Conclusion

Klearchos K. Papas stands out as a prominent inventor whose work has the potential to transform therapeutic approaches and enhance patient care. With a strong focus on innovations that bridge technology and healthcare, his inventions continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…